1. Home
  2. WRBY vs AMPH Comparison

WRBY vs AMPH Comparison

Compare WRBY & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRBY
  • AMPH
  • Stock Information
  • Founded
  • WRBY 2010
  • AMPH 1996
  • Country
  • WRBY United States
  • AMPH United States
  • Employees
  • WRBY N/A
  • AMPH N/A
  • Industry
  • WRBY Ophthalmic Goods
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • WRBY Health Care
  • AMPH Health Care
  • Exchange
  • WRBY Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • WRBY 1.9B
  • AMPH 2.5B
  • IPO Year
  • WRBY 2021
  • AMPH 2014
  • Fundamental
  • Price
  • WRBY $17.23
  • AMPH $51.45
  • Analyst Decision
  • WRBY Buy
  • AMPH Buy
  • Analyst Count
  • WRBY 8
  • AMPH 4
  • Target Price
  • WRBY $16.88
  • AMPH $63.00
  • AVG Volume (30 Days)
  • WRBY 1.4M
  • AMPH 268.7K
  • Earning Date
  • WRBY 11-07-2024
  • AMPH 11-06-2024
  • Dividend Yield
  • WRBY N/A
  • AMPH N/A
  • EPS Growth
  • WRBY N/A
  • AMPH 62.07
  • EPS
  • WRBY N/A
  • AMPH 3.15
  • Revenue
  • WRBY $719,929,000.00
  • AMPH $712,891,000.00
  • Revenue This Year
  • WRBY $15.94
  • AMPH $18.04
  • Revenue Next Year
  • WRBY $13.07
  • AMPH $4.41
  • P/E Ratio
  • WRBY N/A
  • AMPH $16.26
  • Revenue Growth
  • WRBY 13.67
  • AMPH 31.80
  • 52 Week Low
  • WRBY $9.83
  • AMPH $36.56
  • 52 Week High
  • WRBY $18.37
  • AMPH $65.92
  • Technical
  • Relative Strength Index (RSI)
  • WRBY 57.79
  • AMPH 59.40
  • Support Level
  • WRBY $16.71
  • AMPH $49.38
  • Resistance Level
  • WRBY $17.86
  • AMPH $51.84
  • Average True Range (ATR)
  • WRBY 0.66
  • AMPH 1.25
  • MACD
  • WRBY 0.01
  • AMPH 0.10
  • Stochastic Oscillator
  • WRBY 62.77
  • AMPH 78.90

About WRBY Warby Parker Inc.

Warby Parker Inc is engaged in designing and developing designer prescription glasses and contacts, and providing the facility of eye exams and vision tests. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: